IP Library Assignment 036785/0158
Patent Assignment
Reel/Frame 036785/0158

Security Interest

Recorded: 2015-10-13 Pages: 19
Assignor
Assignee
DOMINION CAPITAL, LLC
341 WEST 38TH STREET, NEW YORK, NEW YORK, 10018
Covered Properties (14)
Methods, Systems, and Composition Related to Neural Disorders
VH4 Antibodies Against Gray Matter Neuron and Astrocyte
Methods for Evaluating Neurological Disease
Methods and Compositions for the Protection of Sensory Cells
Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof
Patent: 8,084,425 →
Application: 12/535,029 →
Publication: US 2010/0119491
Method of Enhancing Dopaminergic Neuronal Cell Growth or Survival with MANF
Application: 12/934,454 →
Publication: US 2011/0212055
Microrna Profiles for Evaluating Multiple Sclerosis
Application: 13/165,492 →
Publication: US 2012/0015830
Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof
Patent: 9,115,208 →
Application: 13/305,025 →
Publication: US 2013/0078220
Methods and Reagents for Evaluating Autoimmune Disease and Determining Antibody Repertoire
Application: 14/475,007 →
Publication: US 2014/0371103
Microrna Signatures Indicative of Immunomodulating Therapy for Multiple Sclerosis
Application: 14/481,363 →
Publication: US 2015/0057181
Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof
Application: 14/755,272 →
Publication: US 2016/0152673
Methods and Compositions for Treating Retinal Disorders
Application: 62/060,199 →
Methods and Compositions for Improved Visual Acuity
Application: 62/084,279 →
Methods for Diagnosing Multiple Sclerosis Using VH4 Antibody Genes
Application: 62/112,942 →
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2012
From: BIGWOOD, DOUGLAS W.; EASTMAN, ERIC M.; ELASHOFF, MICHAEL
To: DIGOENIX, INC.
Reel/Frame 027516/0723 →
Assignment of Assignor's Interest Nov 10, 2014
From: EASTMAN, ERIC M.; BIGWOOD, DOUGLAS W.
To: DIOGENIX, INC.
Reel/Frame 034140/0327 →
Assignment of Assignor's Interest Nov 20, 2014
From: BIGWOOD, DOUGLAS W.; EASTMAN, ERIC M.
To: DIOGENIX, INC.
Reel/Frame 034220/0146 →
Assignment of Assignor's Interest Feb 18, 2015
From: URFER, ROMAN
To: AMARANTUS BIOSCIENCE HOLDINGS, INC.
Reel/Frame 035033/0558 →
Assignment of Assignor's Interest Jun 24, 2015
From: COMMISSIONG, JOHN; RAIBEKAS, ANDREI
To: PRESCIENT NEUROPHARMA, INC.
Reel/Frame 035897/0364 →
Assignment of Assignor's Interest Jun 24, 2015
From: PRESCIENT NEUROPHARMA, INC.
To: EMS DEVELOPMENT GROUP, LLC
Reel/Frame 035897/0420 →
Assignment of Assignor's Interest Jun 24, 2015
From: PRESCIENT NEUROPHARMA, INC.
To: EMS DEVELOPMENT GROUP, LLC
Reel/Frame 035963/0737 →
Assignment of Assignor's Interest Jun 24, 2015
From: EMS DEVELOPMENT GROUP, LLC
To: CNS PROTEIN THERAPEUTICS, INC.
Reel/Frame 035963/0754 →
Change of Name Jun 24, 2015
From: CNS PROTEIN THERAPEUTICS, INC.
To: AMARANTUS THERAPEUTICS, INC.
Reel/Frame 036016/0721 →
Assignment of Assignor's Interest Jul 29, 2015
From: WILKS, TOM
To: AMARANTUS BIOSCIENCE HOLDINGS, INC.
Reel/Frame 036213/0046 →
Corrective Assignment to Correct the Company Name on the Assignment Previously Recorded on Reel 027516 Frame 0723. Assignor(S) Hereby Confirms the the Company Name Is Diogenix, Inc.. Jul 29, 2015
From: BIGWOOD, DOUGLAS W.; EASTMAN, ERIC M.; ELASHOFF, MICHAEL
To: DIOGENIX, INC.
Reel/Frame 036225/0296 →
Assignment of Assignor's Interest Oct 5, 2015
From: URFER, ROMAN
To: AMARANTUS BIOSCIENCE HOLDINGS, INC.
Reel/Frame 036727/0839 →
Assignment of Assignor's Interest Sep 22, 2016
From: DIOGENIX, INC.
To: AMARANTUS BIOSCIENCE HOLDINGS, INC.
Reel/Frame 039833/0646 →
Assignment of Assignor's Interest Dec 20, 2017
From: PRESCIENT NEUROPHARMA, INC.
To: EMS DEVELOPMENT GROUP, LLC
Reel/Frame 044446/0779 →
Change of Name Dec 20, 2017
From: CNS PROTEIN THERAPEUTICS, INC.
To: AMARANTUS THERAPEUTICS, INC.
Reel/Frame 044918/0879 →
Assignment of Assignor's Interest Dec 20, 2017
From: EMS DEVELOPMENT GROUP, LLC
To: CNS PROTEIN THERAPEUTICS, INC.
Reel/Frame 044446/0808 →
Assignment of Assignor's Interest Dec 20, 2017
From: COMMISSIONG, JOHN; RAIBEKAS, ANDREI
To: PRESCIENT NEUROPHARMA, INC.
Reel/Frame 044446/0772 →